Inventor · disambiguated record
Jonathan Braun
Also filed as: BRAUN JONATHAN
30 granted patents·8 pending applications·452 citations·filing 1994–2018
96Inventor score
Files withUNIV CALIFORNIA27BRAUN JONATHAN4CEDARS SINAI MEDICAL CENTER4GORDON LYNN K1US GOV DEPT OF VETERANS AFFAIRS1
Top patents by PatentIndex Score
38 records- 0194US6309643B1IBD-associated microbial antigens and methods of using sameUNIV CALIFORNIA·Filed 1999·Granted Oct 30, 2001·113 cites·11 claims
- 0293US6033864ADiagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigensUNIV CALIFORNIA·Filed 1998·Granted Mar 7, 2000·132 cites·15 claims
- 0388US5691151AMethods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and pancaUNIV CALIFORNIA·Filed 1994·Granted Nov 25, 1997·76 cites·66 claims
- 0487US10413577B2Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong lifeUNIV CALIFORNIA·Filed 2017·Granted Sep 17, 2019·6 cites·23 claims
- 0583US7993865B2Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigenCEDARS SINAI MEDICAL CENTER·Filed 2006·Granted Aug 9, 2011·4 cites·11 claims
- 0682US7138237B1Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigenUNIV CALIFORNIA·Filed 2000·Granted Nov 21, 2006·35 cites·16 claims
- 0781US8445200B2Genotoxicity as a biomarker for inflammationWESTBROOK AYA M·Filed 2010·Granted May 21, 2013·6 cites·26 claims
- 0879US8318906B2EMP2 antibodies and their therapeutic usesBRAUN JONATHAN·Filed 2008·Granted Nov 27, 2012·6 cites·15 claims
- 0979US7993866B2Diagnosis, prevention and treatment of crohn's disease using the OmpC antigenCEDARS SINAI MEDICAL CENTER·Filed 2009·Granted Aug 9, 2011·4 cites·9 claims
- 1079US7993867B2Diagnosis, prevention and treatment of crohn's disease using the OmpC antigenCEDARS SINAI MEDICAL CENTER·Filed 2009·Granted Aug 9, 2011·4 cites·12 claims
- 1176US7183065B2Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigensUNIV CALIFORNIA·Filed 2002·Granted Feb 27, 2007·9 cites·13 claims
- 1274US10028983B2Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong lifeUNIV CALIFORNIA·Filed 2014·Granted Jul 24, 2018·4 cites·15 claims
- 1374US6320037B2IBD-associated microbial nucleic acid moleculesUNIV CALIFORNIA·Filed 2001·Granted Nov 20, 2001·5 cites·2 claims
- 1472US6759530B2IBD-associated microbial nucleic acid moleculesUNIV CALIFORNIA·Filed 2001·Granted Jul 6, 2004·4 cites·28 claims
- 1570US8940491B2Genotoxicity as a biomarker for inflammationUNIV CALIFORNIA·Filed 2014·Granted Jan 27, 2015·0 cites·20 claims
- 1670US6821739B2Methods of diagnosing and treating Crohn's disease using Pseudomonas antigensUNIV CALIFORNIA·Filed 2001·Granted Nov 23, 2004·5 cites·8 claims
- 1767US8951740B2Genotoxicity as a biomarker for inflammationUNIV CALIFORNIA·Filed 2013·Granted Feb 10, 2015·0 cites·17 claims
- 1867US7557194B2Antibody materials for an IBD-associated polypeptideUNIV CALIFORNIA·Filed 2004·Granted Jul 7, 2009·2 cites·5 claims
- 1960US2011124644A1Methods of diagnosing and characterizing cannabinoid signaling in crohn's diseaseCEDARS SINAI MEDICAL CENTER·Filed 2009·Application pending·0 cites
- 2059US5691135AImmunoglobulin superantigen binding to gp 120 from HIVUNIV CALIFORNIA·Filed 1994·Granted Nov 25, 1997·22 cites·3 claims
- 2158US8785602B2EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereofUNIV CALIFORNIA·Filed 2013·Granted Jul 22, 2014·0 cites·16 claims
- 2257US9011857B2Methods of treating cancer by administering EMP2 antibodiesUNIV CALIFORNIA·Filed 2012·Granted Apr 21, 2015·0 cites·6 claims
- 2357US8779104B2EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereofUNIV CALIFORNIA·Filed 2013·Granted Jul 15, 2014·0 cites·16 claims
- 2455US5738847AAnti-VH3-15 reagents and methods for their useUNIV CALIFORNIA·Filed 1994·Granted Apr 14, 1998·11 cites·10 claims
- 2553US9624304B2Antibodies which bind to epithelial membrane protein 2 (EMP2)UNIV CALIFORNIA·Filed 2015·Granted Apr 18, 2017·0 cites·10 claims
- 2651US11053310B2Antibodies for the treatment of cancersUNIV CALIFORNIA·Filed 2016·Granted Jul 6, 2021·0 cites·8 claims
- 2750US9110064B2Methods for diagnosis and treatment of endometrial cancerBRAUN JONATHAN·Filed 2011·Granted Aug 18, 2015·0 cites·3 claims
- 2847US2010196509A1Methods for Diagnosis and Treatment of Endometrial CancerBRAUN JONATHAN·Filed 2006·Application pending·0 cites
- 2946US2014234308A1Treatment of breast cancer with companion diagnosticUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 3045US2019077852A1Anti-emp2 therapy reduces cancer stem cellsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3145US2015329621A1Anti-emp2 therapy reduces cancer stem cellsUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 3244US10385395B2Diagnostic tools for response to 6-thiopurine therapyUNIV CALIFORNIA·Filed 2013·Granted Aug 20, 2019·0 cites·4 claims
- 3343US6537768B1Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigensUNIV CALIFORNIA·Filed 1999·Granted Mar 25, 2003·4 cites·10 claims
- 3441US8648052B2Prevention of chlamydia infection using SIRNABRAUN JONATHAN·Filed 2007·Granted Feb 11, 2014·0 cites·11 claims
- 3541US2019352399A1Treatment of cancers using anti-emp2 antibody and pd-1/pdl-1 pathway antagonist combination therapyUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3640US2015079089A1Emp2 regulates angiogenesis in cancer cells through induction of vegfUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 3725US2013034555A1Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseasesUS GOV DEPT OF VETERANS AFFAIRS·Filed 2011·Application pending·0 cites
- 3820US9464135B2Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)GORDON LYNN K·Filed 2010·Granted Oct 11, 2016·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →